Last month we alerted you to when the FDA released its hold on the first trial of an embryonic stem cell based treatment for a spinal cord injury. Now it looks as though for the second time, the Food and Drug Administration approved a company’s request to test an embryonic stem cell-based therapy on human patients.
This is such a great news from the life extension perspective. The more successful clinical trials there are, the closer we get to comprehensive cell therapies that have a huge potential not only to alleviate the current health problems, but to rejuvenate our bodies.